Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Unaudited)

v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 1,973,745 $ 864,840
Prepaid expenses and other current assets 165,963 607,670
Total current assets 2,139,708 1,472,510
Total assets 2,139,708 1,472,510
Current liabilities:    
Accounts payable and accrued expenses 1,267,423 1,355,867
Short-term notes payable, net of debt issuance costs 3,000,000 328,528
Total liabilities 4,267,423 1,684,395
Stockholders’ deficit:    
Preferred stock, no par value; 50,000,000 shares authorized; 7,488,692 and 7,488,692 Series F outstanding at June 30, 2025, and December 31, 2024, respectively
Common stock, $0.001 par value; 350,000,000 shares authorized; 822,927 and 419,003 shares issued and outstanding at June 30, 2025, and December 31, 2024, respectively 823 419
Additional paid-in capital 219,146,662 216,573,868
Accumulated deficit (221,275,200) (216,786,172)
Total stockholders’ deficit (2,127,715) (211,885)
Total liabilities and stockholders’ deficit $ 2,139,708 $ 1,472,510